Zobrazeno 1 - 5
of 5
pro vyhledávání: '"María Sagrario Pernía-López"'
Autor:
Lucía Cortejoso-Fernández, Rosa María Romero-Jiménez, María Sagrario Pernía-López, María Montoro-Álvarez, María Sanjurjo-Sáez
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 15, Iss 1 (2011)
Purpose: Abatacept was approved in our hospital by the Pharmacy and Therapeutics Committee for treatment of moderate to severe rheumatoid arthritis (RA) in adult patients with inadequate response or intolerance to disease modifying antirheumatic drug
Externí odkaz:
https://doaj.org/article/f694daf7d36a4ddb9113dc1dcac77cb1
Autor:
Raquel Fuentes-Irigoyen, Ana María Martín de Rosales Cabrera, Ana Cristina Riestra, María Nieves Vila, Carmela Dávila-Pousa, José María Alonso Herreros, Carmen López-Cabezas, Carmen Cañete, María Sagrario Pernía-López, Marta Garcia-Palomo, Pedro Arriola Villalobos, Lucía Ibares-Frías, José Luís Urcelay Segura
Publikováno v:
Farmacia Hospitalaria, Vol 42, Iss 02, Pp 82-88 (2018)
There are many medicinal products that, although having shown efficacy and safety in different ophthalmological indications, they are not authorized or commercially available for ophthalmic administration. This implies, on one hand, that they must be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::171b14d854b2cb0095066e44504d39cb
http://www.aulamedica.es/fh/pdf/10943.pdf
http://www.aulamedica.es/fh/pdf/10943.pdf
Autor:
Ana Herranz-Alonso, María Sanjurjo-Sáez, Esther Chamorro de Vega, Alejandra Melgarejo-Ortuño, Maricela Valerio-Minero, Carmen Guadalupe Rodríguez-González, Xandra García-González, María Sagrario Pernía-López
Publikováno v:
American journal of therapeutics. 27(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::006315b096ebd784e9dae20e040bc1de
https://pubmed.ncbi.nlm.nih.gov/31356341
https://pubmed.ncbi.nlm.nih.gov/31356341
Autor:
María Montoro-Álvarez, Lucia Cortejoso-Fernandez, María Sanjurjo-Sáez, María Sagrario Pernía-López, RM Romero-Jiménez
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 15, Iss 1 (2011)
Purpose: Abatacept was approved in our hospital by the Pharmacy and Therapeutics Committee for treatment of moderate to severe rheumatoid arthritis (RA) in adult patients with inadequate response or intolerance to disease modifying antirheumatic drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6a3f0030044f1a2a6af7bf5f52d84f
https://doi.org/10.18433/j36s3w
https://doi.org/10.18433/j36s3w
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.